FDA Approves First Disease-Modifying Drug for Rare Anemia
The FDA has approved Agios Pharmaceuticals' Pyrukynd for a rare type of hemolytic anemia.
Source: biospace.com
Agio Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Agio Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.